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Introduction
Diabetes mellitus (DM) remains one of  the most serious 
worldwide health challenges. Diabetic foot infection (DFI) and 
diabetic nephropathy are the major complications of  DM, which 
increases morbidity and mortality of  patients. Among various 
other complications associated with Type 2 Diabetes Mellitus 
(T2DM), DFI and its recurrence represents a significant and 
often challenging clinical problem, which is mainly due to either 
diabetic neuropathy and/or peripheral arterial disease (PAD) [1-4]. 
DFI affects nearly 12 to 25% of  patients with T2DM throughout 
their lives and it is the leading cause for hospital admission among 
diabetic patients in India. This is mainly due to socio-cultural 
factors & lack of  knowledge on diabetic foot complications [5]. 
The etiology of  DFI is multifactorial and the management of  
DFI and its consequences increases the burden on both health 
and social services. In developing countries, the common causes 
of  death after amputation in T2DM patient are infection and 
cardiovascular events. Further myocardial infarction was the most 
common among post amputated T2DM patient in India [6].
Diabetic foot ulcers and renal function in DM show a strong 
correlation between the classifications of  diabetic foot ulcer 
and eGFR [7]. Indians are at heightened risk for nephropathy, 
more than any other ethnic groups and declining of  GFR was 
also faster. T2DM patients in India are at high risk of  developing 
Chronic Kidney disease (CKD) and diabetes is now the leading 
cause of  end stage renal disease (ESRD) in many regions of  India 
[8]. The burden of  CKD among the DM remains to be a global 
threat, as the treatment is expensive and lifelong. In developing 
Abstract
Background: Diabetic foot infection (DFI) and Chronic Kidney Disease (CKD) are two health care issues causing consider-
able burden in the developing world. The current study was aimed to examine the effect of  DFI in declining renal function 
among patients with Type 2 Diabetes Mellitus (T2DM). 
Methods: A total of  412 patients have been included in a prospective 12 months follow-up study. The study patients were 
categorized into Group I: T2DM with CKD and DFI, Group II: T2DM with CKD, Group III: T2DM with DFI and without 
CKD and Group IV- T2DM without any complications. Demographic, anthropometric and clinical parameters were recorded 
accordingly. 
Results: Significant fall in eGFR was observed within group I at 6th month (p<0.0001) and 12th month (p<0.0001). In group 
II fall in eGFR was noticed in 3rd month (p<0.004); 6th month and (p<0.004); 12th months (p<0.0001) and in group III signifi-
cant fall in eGFR was observed in 3rd month (p<0.0001), 6th month (p<0.004) and 12 months (p<0.004). No significant fall 
in eGFR was observed in group IV. The mean differences of  eGFR from 0 to 12 months were 11.01, 8.36, 3.52, and 1.2 in all 
the groups respectively. 
Conclusions: There was a significant reduction in eGFR among CKD patients with DFI and DFI patients without CKD. 
Therefore development of  DFI may cause decline in renal function irrespective of  CKD status and preventive steps to prevent 
a DFI is mandatory in all T2DM.
Keywords: Diabetic Foot Infection; Chronic Kidney Disease; eGFR; T2DM.
*Corresponding Author: 
Vijay Viswanathan, 
Head & Chief  Diabetologist, M.V. Hospital for Diabetes and President, Prof. M.Viswanathan Diabetes Research Centre, No: 4, West Madha Church Street, Royapuram, Chennai, 600013, 
Tamil Nadu, India.
E-mail: drvijay@mvdiabetes.com/researchcommunication@mvdiabetes.com
 Received: October 17, 2017
 Accepted: November 14, 2017
 Published: November 21, 2017
 Citation: Anitha Rani A, Viswanathan V. Diabetic Foot Infection and Worsening Kidney Function: Implication for Health Care in the Developing World. Int J Diabetol Vasc Dis Res,. 
 2017;5(5):208-213. doi: http://dx.doi.org/10.19070/2328-353X-1700042
 
 Copyright: Viswanathan V©2017. This is an open-access article distributed under the terms of  the Creative Commons Attribution License, which permits unrestricted use, distribution 
and reproduction in any medium, provided the original author and source are credited.
Anitha Rani A, Viswanathan V. Diabetic Foot Infection and Worsening Kidney Function: Implication for Health Care in the Developing World. Int J Diabetol Vasc Dis Res,. 
2017;5(5):208-213. 209
 OPEN ACCESS                                                                                                                                                                                http://scidoc.org/IJDVR.php
countries like India, the direct cost involved in hospital admission 
for treating diabetic patients with CKD was considerably higher 
when compared to that of  diabetic patients without CKD [9]. In a 
large cohort of  90, 617 diabetic subjects with, a strong association 
between the degree/severity of  renal impairment and the onset 
of  both diabetic foot ulcer and lower extremity amputation was 
demonstrated [10]. T2DM patients with ESRD on dialysis with 
foot ulcer, shows significant association with PVD [11]. Most 
of  these studies emphasized the association between CKD and 
peripheral arterial disease rather than with DFI [12, 13]. CKD is 
an independent risk factor for the development of  foot lesions in 
the diabetic population [14]. Though there is a close association 
between CKD and DFI it does not prove a causal relationship 
between the two conditions [15] and several possible common 
underlying pathophysiological mechanisms may underpin it. 
Although every practicing clinician may have the impression that 
DFI is more common in patients with CKD, there are surprisingly 
very little data on the relationship between DFI and CKD in 
patients with diabetes and majority of  studies have investigated 
only among dialysis patients [10, 16, 17]. There is a paucity of  data 
which focused on the overall occurrence of  DFI among those 
with CKD and diabetes. Hence the main objective of  this study 
was to investigate the effect of  Diabetic foot infection (DFI) on 
the renal function among patients with and without CKD at the 
time of  onset of  DFI. 
Research Design and Methods
Prospective follow up study was conducted among the patients 
with T2DM, who attended the outpatient Diabetes clinic during 
the study period of  October 2014 to March 2017 in a tertiary care 
hospital in India. Study population includes age matched patients 
with T2DM with pre-existing diabetic kidney disease (stage 2 and 
3 CKD and with a DFI (grade 2 and 3: University of  Texas foot 
ulcers grading), patients with T2DM with pre-existing kidney 
disease (stage 2 and 3 CKD) without DFI, Diabetic patients 
with foot ulcers and T2DM subjects without any complications. 
Patients aged ≥ 25 years with duration of  diabetes more than 
three years were included in the study. 
Patients with severe and or progressive foot infection, any acute 
concurrent illness in the previous 6 months (e.g. malignancy, severe 
gastrointestinal disease), history of  non-diabetic or obstructive 
kidney disease, history of  a cardiovascular or cerebrovascular 
accident, diabetic foot ulcers which had not healed within six 
months, patients with type 1 diabetes and gestational diabetes and 
those with incomplete laboratory data were excluded from the 
study.
Assessment of  Foot/Ulcers
Diabetic Foot Ulcer was categorized based on the classification 
of  the University Of  Texas Health Science Center San Antonio 
(UT). Neuropathy was identified using the Biothesiometer (from 
diabetic foot care India Pvt. Ltd.) to determine the vibration 
perception threshold (a value of  ≥ 25 volts was considered as 
abnormal) and peripheral arterial disease was determined using 
peripheral vascular Doppler (Versalab).
Assessment of  Renal Function
Study subjects were grouped into the CKD stages according to 
the eGFR (CKD EPI formula) and presence of  albuminuria for 
three consecutive visits. The eGFR was calculated based on CKD 
- EPI equation which expressed as a single equation as [18]:
eGFR = 141 × min ((Scr/κ,)1)α × max((Scr/κ),1)-1.209 × 0.993Age × 
1.018 [if  female]× 1.159 [if  black]
Stratification of  CKD was based on the eGFR stages as per 
KDOQI guidelines [19]. Pre-existing diabetic kidney disease 
(DKD) was defined as a history of  an elevated urinary albumin 
excretion rate (UAER - immunoturbidimetric method) using an 
overnight timed urine collection (range: < 20µg/min - Normal; 
>20µg/min-Abnormal), associated with reduced eGFR. 
Creatinine was estimated by Jaffe’s kinetic method (this enzymatic 
kinetic test was carried out without deproteinization, [20]), urinary 
albumin was estimated by immuno-turbidimetric procedure 
and Urinary protein was determined using pyrogallol method 
(biochemical method). Estimated glomerular filtration rate and 
albumin creatinine ratio were used for assessing renal function. 
Estimated glomerular filtration rate was calculated based on CKD 
- EPI equation. This equation was developed in 2009 [18] and 
intended to be more generalizable across various clinical settings.
Clinical and Biochemical Investigations
Demographic and anthropometric details like age, height, 
weight, blood pressure, duration of  diabetes, medical history, 
family history of  diabetes, history of  kidney disease, foot ulcer, 
history of  micro and macro vascular complications, history of  
hypertension, history of  smoking and alcohol were obtained from 
patients proforma and medical records of  the study subjects. 
Basic blood parameters like Fasting blood glucose (GOD – POD 
method), postprandial blood glucose (GOD – POD method), 
HbA1c (HPLC method using variant turbo equipment [Bio-Rad]), 
renal function test and lipid profile (Total Cholesterol - CHOD 
- PAP method, Triglyceride - GPO method, HDL and LDL - 
Direct IMM) were measured for all the study subjects. All other 
biochemical parameters were estimated using BS400 biochemistry 
auto analyzer. Diagnosis of  T2DM subjects was selected based 
on previous history of  diabetes and the criteria of  the World 
Health Organization. The study was approved by the Institutional 
Research committee.
Statistical Analysis
Data were presented in mean (±) Standard deviation. Student’s 
t test was used to compare continuous variable, Chi-square test 
was used to compare the proportions between the study groups. 
ANOVA was used for comparison of  quantitative variables. 
Difference in time period was analyzed using ANOVA for 
repeated measures with the four groups (CKD+DFI, CKD, DFI 
and T2DM) as between subject factor and different months as 
within subject factor. Multiple comparisons were performed 
using bonferroni correction for all the study groups Mauchly’s 
test indicated that the assumption of  sphericity has been violated, 
therefore degrees of  freedom were corrected using Greenhouse-
Geisser estimates of  sphericity (ϵ = 0.892). A p value of  <0.05 
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was considered statistically significant. All statistical analyses were 
performed using Statistical Package for the Social Sciences (SPSS) 
Version 20, (Illinois, USA) software.
Results
A total of  412 T2DM patients (Male: Female/250:162) were 
recruited based on the inclusion and exclusion criteria for a 
prospective study with a 12 month follow-up period (0, 3rd, 
6th and 12th month). Based on CKD and DFI, study subjects 
were categorized into four groups. Group I includes diabetic 
subjects with chronic kidney disease and diabetic foot infection 
(CKD+DFI, n=93), group II includes diabetic subjects with 
chronic kidney disease without DFI (CKD, n=97), group III 
includes diabetic subjects with foot infection and without CKD 
(DFI, n=108) and group IV included type 2 diabetic subjects 
without any complications (T2DM, n=114). 
Table 1 shows the demographic, anthropometric and clinical details 
of  all the study groups. Statistical significance were observed in 
age (P<0.001), gender (P<0.005) duration of  diabetes (P<0.001) 
and duration of  hypertension (<0.001). Neuropathy was higher in 
group I (34.5 %) followed by group III (33 %) and group II (12 
%) respectively. Presence of  retinopathy was higher in group II 
(32 %), followed by group I (19 %) and group III (7.7 %). Among 
the study groups presence of  both neuropathy and retinopathy 
was higher in group III (11.9 %). 
The effect of  time on eGFR of  different groups (within subject 
effect), shows significant difference, which is reflected by repeated 
measure ANOVA, using Mauchly's test of  Sphericity, (P<0.0001), 
the Greenhouse-Geisser correction was also statistically significant, 
(F=9.016; P<0.0001) (Figure 1). The mean differences of  eGFR 
from 0 to 12 months were 11.01, 8.36, 3.52, and 1.2 in all the 
groups respectively (Figure 2). Table 2 represents the eGFR of  
all the study groups. Significant fall in eGFR was observed within 
group I at 6th month (p<0.0001) and 12th month (p<0.0001). In 
group II fall in eGFR was noticed in 3rd month (p<0.004); 6th 
month and (p<0.004); 12th months (p<0.0001) and in group III 
significant fall in eGFR was observed in 3rd month (p<0.0001), 
6th month (p<0.004) and 12 months (p<0.004). No significant fall 
in eGFR was observed in group IV. Time and group interaction 
is significant which indicates the effect of  eGFR over the time 
is different for different group. The mean trend is significantly 
different in eGFR over the period of  time in all the groups (Table 
3).
Table 4 shows the comparison of  reduction in eGFR among 
different groups from baseline to follow up. When comparing the 
0 Vs 6th month eGFR, reduction was significantly higher in Group 
I (CKD and DFI: 6.85 ml), followed by group III (DFI: 4.10) and 
group II (CKD: 4.25). When comparing the 6th Vs 12th month 
eGFR, in the CKD group there was a significant reduction in 
Table 1. Demographic and anthropometric characteristic of  the study groups.
Characteristic Group I Group II Group III Group IV P- Value
Ages (yrs) 58.6 ± 8.96 59.2 ± 8.09 59.8 ± 8.33 58.7 ± 10.75 0.76
Gender (M:F) 65:28 68:29 56:52 61:53 0.005
Duration of  Diabetes (yrs) 11.4 ± 6.40 13.5 ± 7.17 11.6 ± 6.22 9.4 ± 5.29 <0.001
Duration of  Hypertension (yrs) 5.45 ± 2.75 4 ± 2.4 4.38 ± 2.71 1.54 ± 1.56 <0.001
Family history of  Diabetes (%) 51.60 60.80 61.10 72.80 0.018
Smoking (%) 4.25 7.20 3.70 7.90 0.138
Alcohol (%) 2.20 6.20 8.30 4.40 0.326
Neuropathy (%) 34.5 12 33 -
Retinopathy (%) 19 32 7.7 -
Neuropathy & Retinopathy (%) 15 12 11.9 -
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eGFR and similar fall in eGFR was observed in CKD with DFI 
group. Whereas in the DFI group, the reduction of  eGFR was 
similar to the reduction observed in group 4 (T2DM). The wound 
healing time in DFI group was 40.8 days (1.5 months), where as 
in CKD with DFI group the healing time was 60.5 days which is 
2 months. 
Discussion
To our knowledge this is the first study of  this kind to study the 
role of  DFI on the renal function at the time of  onset of  DFI. 
Diabetic foot ulcers occurs significantly more often in patients 
with nephropathy, macroalbuminuria, end-stage renal disease, but 
not in those with microalbuminuria [21]. Diabetic foot infection 
appears to contribute towards an Acute Kidney Injury (AKI) 
like situation in people with Diabetes. Although there are many 
potential mechanisms used to explain the onset of  CKD & DFI 
in diabetes, it is fascinating to note that structurally in many 
ways the onset of  CKD is similar to the onset of  DFI [6]. At 
the same time, there are no plausible mechanisms through which 
DFI could have a direct/causal impact among patients with 
CKD. These two complications perhaps share common/similar 
pathophysiological mechanisms such as increased inflammation, 
endothelial dysfunction and oxidative stress. Further they shares 
common risk factors such as obesity, hypertension, duration of  
diabetes and older age [22-24]. Causal pathways to foot ulceration 
are multifactorial and involve combinations of  physiological and 
mechanical factors, self-care, and treatment factors. Diabetic 











0-GFR 3-GFR 6-GFR 12-GFR




Comparision of  eGFR from 0 - 12 months
Table 2. Comparison of  eGFR from baseline to follow up in all the groups.
Group 0 Month GFR 3rd Month GFR 6th Month GFR 12th Month GFR
G1 CKD and DFI 60.2 ± 18.95 57.75 ± 18.51 53.39 ± 14.97* 49.19 ± 13.92*
G2 CKD 51.88 ± 17.48 49.05 ± 16.66** 47.63 ± 16.18** 43.52 ± 14.53*
G3 DFI 75.13 ± 16.07 69.57 ± 17.14* 71.03 ± 14.87** 71.61 ± 13.7**
G4 T2DM 82.06 ± 9.64 82.32 ± 14.04 81.19 ± 14.87 80.86 ± 13.55
P value <0.0001*, P< 0.004** is considered statistically significant.
Table 3. Trend Analysis for all the Groups over the Time Period.
Source Time Type III Sum of  Squares df Mean Square F Sig.
Time vs Group
Linear 2459.759 3 819.92 13.228 <0.0001
Quadratic 1036.605 3 345.535 7.586 <0.0001
Cubic 280.335 3 93.445 2.911 0.034
Table 4. Comparison of  eGFR from baseline to follow up within the group.
Group eGFR Reduction (ml/ min/1.73sqm body surface area)
0 month Vs 6th month eGFR 6th month Vs 12th month eGFR
G1 CKD + DFI 6.85 (<0.0001)* 4.20 (<0.0001) *
G2 CKD 4.25 (0.002)* 4.11 (<0.0001)*
G3 DFI 4.10 (0.001)* 0.58 (0.004)**
G4 T2DM 0.87 (0.689) 0.33 (0.79)
P value < 0.0001*, P < 0.004** is considered statistically significant. 
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nephropathy has been identified to be an important risk factor 
for DFI and amputation [25, 26]. Present highlighted that in 
patients with DFI there is a reduction in eGFR and when the 
infection subsides the eGFR improved, whereas in patients with 
pre-existing CKD the decrease in eGFR was observed in all the 
follow-up periods. Among patients with both CKD and DFI, fall 
in eGFR was similar to that of  DFI patients, however the eGFR 
continues to fall and fails to improve after the DFI subsides. Thus 
DFI seems to worsen the CKD stage, as the fall in eGFR was 
higher in CKD with DFI group. A significant finding in this study 
is the fact that there is a reduction of  eGFR among patients DFI 
with normal eGFR before DFI. Further this study also found that 
the healing time was also high in patients with CKD and DFI 
group, when compared with that of  DFI group. AKI and CKD 
share common risk factors and disease modifiers. When AKI 
occurs without preexisting kidney disease, CKD may still develop. 
Conversely, the presence of  CKD is an important risk factor for 
the development of  AKI. 
The underlying mechanism in the progression of  renal dysfunction 
is incompletely understood, animal model studies showed several 
casual pathways which includes either disordered regeneration 
or maladaptive repair or both may initiate the ongoing organ 
dysfunction [27]. Reduced GFR higher than normal range in 
people with diabetes tend to aggravate DFI and ultimately 
leads to amputation [28]. Renal disease after AKI episodes can 
be determine by the reduction in eGFR, temporal balance of  
effective and maladaptive repair reversibility of  the injury and 
regenerative mechanism [29]. 
In the present study, conducted among patients with minimal to 
moderate CKD (stage 2 & 3); DFI appears to worsen the eGFR 
decline. DFI healing is worst in patients with higher creatinine 
levels. Patients with declining eGFR are prone to DFI. In a 
developing country, the burden of  CKD is higher [8] and it is further 
escalated due to DFI. If  DFI occurs in patients with CKD stage 
3 and stage 4, it may worsen the GFR decline and lead to ESRD. 
In order to avoid this situation prevention plays a major role. Foot 
infection in developing countries is a neglected condition [30]. The 
consequences of  persistent and poorly controlled hyperglycemia 
lead to neuropathic and vascular abnormalities that cause foot 
deformities, ulceration and incidence of  foot infection. There is a 
need to increase the awareness on diabetes and its complications 
by advocating a healthy life style and emphasizing the importance 
of  simple measures like maintaining the blood pressure and blood 
sugar under control, reducing salt intake, reducing smoking and 
alcohol habits and following good practices like proper foot care.
Conclusion
The present study concluded that there is greater decline in 
eGFR among CKD patients who developed foot infection and 
also among DFI patients with no evidence of  CKD at baseline. 
There is a strong association between the degree of  renal 
function impairment and diabetic foot ulcers. The levels of  
eGFR drop significantly with the onset of  diabetic foot infection 
among T2DM patients with kidney disease. Thus development 
of  DFI per se may cause decline in renal function irrespective 
of  CKD status. Every effort must be taken to prevent DFI in 
people with diabetes especially among those with a lower eGFR. 
Hence DFI has to be actively treated to prevent a decline in 
eGFR. The health care system has to focus on the early healing 
of  wound by imparting education and treatment modalities. A 
multidisciplinary approach is needed to reduce the development 
of  DFI in people with diabetes. The health care system should 
involve a diabetologist and a podiatrist for the prevention and the 
management of  Diabetic foot infection.
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